Mark Aagren

Mark Aagren is the Head of Global HEOR & RWE at LEO Pharma, where they lead the generation of health economic and outcomes research evidence for the company's product portfolio. With extensive experience in the healthcare industry, they previously held roles at Novo Nordisk, including Director of Market Access & HEOR, where they provided strategic guidance for global market access. Mark's expertise encompasses payer marketing, negotiations, health economics, and public affairs, establishing them as a leader in their field. They earned a Master of Science in Economics from the University of Copenhagen and began their career as a student at the Indenrigs- og Sundhedsministeriet.